New appointment at GVK Biosciences
This article was originally published in Scrip
Executive Summary
The Indian CRO GVK Biosciences has appointed Dr Shoibal Mukherjee senior vice-president of clinical development. Dr Mukherjee has previously held senior positions at Ranbaxy and Pfizer. GVK has also appointed Dr William Harel vice-president of business development in the west coast of the US. Dr Harel has more than 20 years' experience in various companies, including Chiron, AAI Pharma and Neeman Medical International.